Tuscan Ridge Asset Management’s Edwards Lifesciences EW Stock Holding History

Tuscan Ridge Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,700	Closed	-$418K	–	284
2019 Q3	$418K	Buy	5,700 +2,700	+90%	+$190K	0.02%	540
2019 Q2	$185K	Sell	3,000 -900	-23%	-$54.4K	0.01%	617
2019 Q1	$249K	Buy	+3,900	New	+$223K	0.02%	553

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Tuscan Ridge Asset Management's EW Position: Q4 2019 in Review

Tuscan Ridge Asset Management sold out of Edwards Lifesciences (EW) in Q4 2019, closing a stake of 5,700 shares — an estimated $418K sold.

Tuscan Ridge Asset Management first reported a position in EW in Q1 2019 and held it in 3 quarters. The position peaked at $418K in Q3 2019. 1,092 funds tracked by Wall St. Rank hold EW as of Q4 2019.

Tuscan Ridge Asset Management reported no remaining Edwards Lifesciences position as of Q4 2019 after selling out during the quarter.
Tuscan Ridge Asset Management sold 5,700 Edwards Lifesciences shares in Q4 2019, an estimated $418K.
Tuscan Ridge Asset Management first reported a position in Edwards Lifesciences in Q1 2019 and held it in 3 quarters.
Tuscan Ridge Asset Management's Edwards Lifesciences position peaked at $418K in Q3 2019.
1,092 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2019.

Based on Tuscan Ridge Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.